Ismayilov, R. And BALCI, C. 2022. Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY , vol.70, no.5 , 1584-1585.

Ismayilov, R., & BALCI, C., (2022). Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY , vol.70, no.5, 1584-1585.

Ismayilov, Rashad, And CAFER BALCI. "Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure," JOURNAL OF THE AMERICAN GERIATRICS SOCIETY , vol.70, no.5, 1584-1585, 2022

Ismayilov, Rashad And BALCI, CAFER. "Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure." JOURNAL OF THE AMERICAN GERIATRICS SOCIETY , vol.70, no.5, pp.1584-1585, 2022

Ismayilov, R. And BALCI, C. (2022) . "Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure." JOURNAL OF THE AMERICAN GERIATRICS SOCIETY , vol.70, no.5, pp.1584-1585.

@article{article, author={Rashad Ismayilov And author={CAFER BALCI}, title={Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure}, journal={JOURNAL OF THE AMERICAN GERIATRICS SOCIETY}, year=2022, pages={1584-1585} }